Supernus Announces FDA Approval of Qelbree™ (SPN-812) for the Treatment of ADHD
Qelbree (viloxazine extended-release capsules) represents the first novel non-stimulant treatment for ADHD in a decade Supernus plans to make Qelbree...
Month: April 2021
Termination of the business combination with Second Sight Medical Products, Inc.
Termination of the business combination with Second Sight Medical Products, Inc. Paris, France, April 3, 2021 – Considering the private...
DBV Technologies Announces Appointment of Timothy E. Morris to Board of Directors
Montrouge, France, April 2, 2021DBV Technologies Announces Appointment of Timothy E. Morris to Board of Directors DBV Technologies (Euronext: DBV...
Emergent BioSolutions Announces Topline Data from NIAID Phase 3 ITAC Trial (INSIGHT-013) Evaluating Immunoglobulins as a Treatment for Hospitalized Patients with COVID-19
GAITHERSBURG, Md., April 02, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today provided an update on the evaluation of...
WW International Announces Refinancing Of Debt Maturities
NEW YORK, April 02, 2021 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (the “Company”) announced today that it has...
SmileDirectClub Announces Appointment of Ted Ward to Board of Directors
AdAge Power Player Brings to Company’s Board More Than Three Decades of Marketing Expertise as GEICO CMONASHVILLE, Tenn., April 02,...
Allarity Therapeutics Submits Premarket Approval Application to U.S. FDA for DRP® Companion Diagnostic for Dovitinib
- Submission precedes expected NDA filing for dovitinib in 2021 - Premarket Approval will allow U.S. marketing of DRP-Dovitinib as...
Coloplast A/S – Trading in Coloplast shares by board members, executives or associated persons
Please see enclosed pdf. Attachment 02042021_trading_in_shares_ARA
NKMax America Announces Corporate Name Change to NKGen Biotech
SANTA ANA, Calif., April 02, 2021 (GLOBE NEWSWIRE) -- NKMax America, a biotechnology company harnessing the power of the body's...
Nyxoah to Delay Full Year 2020 Earnings Release Until April 9, 2021
Nyxoah to Delay Full Year 2020 Earnings Release Until April 9, 2021 Mont-Saint-Guibert, Belgium – 2 April 2021 – Nyxoah...
Monthly information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2021
Monthly information regarding the total number of voting rights and total number of shares of the Company as of March...
Aveanna Files Registration Statement for Proposed Initial Public Offering
ATLANTA, April 01, 2021 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) today announced that it has filed a registration...
Vyant Bio Announces Investor Webcast to Provide Updates Post Merger between Cancer Genetics and StemoniX
CHERRY HILL, N.J., April 01, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (the “Company”) (Nasdaq: VYNT), is a new force...
Chembio Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and Flu
In-licensed Rapid Point-of-Care Test Available for Use in Detecting COVID-19 Antigens, Flu A and Flu B from a Single Patient...
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
FARMINGTON HILLS, Mich., April 01, 2021 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), today announced that the Compensation Committee...
The Pennant Group Acquires Colorado Home Health Provider
EAGLE, Idaho, April 01, 2021 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant...
Integra LifeSciences Appoints Shaundra Clay as Director
Shaundra Clay Shaundra Clay Appointed to the Board of Integra LifeSciences PRINCETON, N.J., April 01, 2021 (GLOBE NEWSWIRE) -- Integra...
Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia and SEATTLE, April 01, 2021 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused...
WW International Announces Pricing of $500 Million of its 4.500% Senior Secured Notes Due 2029
NEW YORK, April 01, 2021 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (the “Company”) announced today that it has...
Natus Medical to Hold 2021 First Quarter Financial Results Conference Call on May 6th
PLEASANTON, Calif., April 01, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider...